AFREZZA

Mannkind Corporation🇺🇸 United States

FDA Page

Effective Date: May 30, 2026
Approval ID: 29f4637b-e204-425b-b89c-7238008d8c10
Products: 7 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AFREZZA safely and effectively. See full prescribing information for AFREZZA. AFREZZA (insulin human) inhalation powder, for oral inhalation use Initial U.S. Approval: 2014

Quick Stats

Total Products7

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.